Table 2.
Protocol 2. Forearm and systemic haemodynamics during graded infusions of ATP and adenosine
| Condition/dose | Forearm blood flow (ml min−1) | Mean arterial pressure (mmHg) | Forearm vascular conductance (ml min−1 (100 mmHg)−1) | Heart rate (beats min−1) |
|---|---|---|---|---|
| Baseline | ||||
| Adenosine 1 | 21 ± 4 | 86 ± 3 | 25 ± 5 | 58 ± 5 |
| ATP 1 | 23 ± 3 | 86 ± 3 | 27 ± 4 | 59 ± 5 |
| Adenosine 2 | 23 ± 3 | 86 ± 3 | 27 ± 4 | 58 ± 5 |
| ATP 2 | 22 ± 3 | 86 ± 3 | 26 ± 4 | 59 ± 4 |
| Adenosine 3 | 23 ± 3 | 86 ± 3 | 28 ± 4 | 60 ± 5 |
| ATP 3 | 24 ± 3 | 86 ± 3 | 28 ± 4 | 59 ± 5 |
| Pre-phenylephrine | ||||
| Adenosine 1 | 51 ± 8* | 86 ± 3 | 61 ± 9* | 60 ± 5 |
| ATP 1 | 50 ± 9* | 84 ± 3 | 61 ± 12* | 58 ± 5 |
| Adenosine 2 | 66 ± 9* | 87 ± 2 | 77 ± 11* | 59 ± 5 |
| ATP 2 | 66 ± 9* | 86 ± 3 | 78 ± 12* | 59 ± 5 |
| Adenosine 3 | 90 ± 12* | 87 ± 3 | 105 ± 14* | 60 ± 5 |
| ATP 3 | 88 ± 13* | 84 ± 3 | 106 ± 17* | 59 ± 5 |
| Phenylephrine | ||||
| Adenosine 1 | 33 ± 6*† | 88 ± 4 | 38 ± 7*† | 60 ± 5 |
| ATP 1 | 35 ± 7*† | 87 ± 3 | 41 ± 9*† | 59 ± 5 |
| Adenosine 2 | 36 ± 6*† | 90 ± 3* | 41 ± 8*† | 59 ± 5 |
| ATP 2 | 53 ± 10*† | 88 ± 4 | 62 ± 12*† | 58 ± 5 |
| Adenosine 3 | 43 ± 8*† | 90 ± 4* | 50 ± 10*† | 60 ± 5 |
| ATP 3 | 79 ± 11*‡ | 86 ± 3 | 94 ± 14*‡ | 59 ± 5 |
P< 0.05 vs baseline within condition;
P< 0.05 vs steady-state (Pre-vasoconstrictor; Phenylephrine) within condition;
P< 0.05 vs adenosine during phenylephrine (α1-agonist) infusion. 1 = Low dose condition; 2 = Moderate dose condition; 3 = High dose condition (see text for details). Forearm vascular conductance was calculated as (forearm blood flow/mean arterial pressure) × 100.